EASL journals achieve outstanding 2025 Impact Factors in the 2026 Journal Citation Reports
EASL is proud to announce that both of its journals have achieved outstanding new Impact Factors in the 2026 release of the Journal Citation Reports (JCR) by Clarivate™, reflecting their continued scientific…
WHO, Imperial College London and EASL Launch First WHO Collaborating Centre Dedicated to Liver Disease
London, 24 June 2026 — The WHO Regional Office for Europe, Imperial College London and EASL inaugurate the first WHO Collaborating Centre dedicated to liver disease, at a ceremony at Imperial's White…
EASL and Content With Purpose announce ambitious new series exploring The Future of Liver Health
EASL and Content With Purpose (CWP) have announced a new partnership to create The Future of Liver Health, an ambitious digital film series exploring how science, prevention, and innovation are transforming hepatology…
Celebrating Excellence in Hepatology: EASL Congress 2026 Award Ceremonies
EASL is proud to announce the recipients of this year's prestigious awards, which will be presented during EASL Congress 2026 in Barcelona, 27–30 May. The award ceremonies are a highlight of the…
World Health Assembly Adopts Landmark Resolution on Steatotic Liver Disease, Marking a Historic First for Global NCD Policy
PRESS RELEASE Geneva, 22 May 2026 For the first time, liver disease receives formal recognition within the global noncommunicable disease agenda — EASL hails the adoption of WHO resolution EB158/CONF./7 as a…
A tribute to Dr Hannes Hagström
EASL is deeply saddened by the passing of Dr Hannes Hagström, Consultant Hepatologist at Karolinska University Hospital and Professor at Karolinska Institutet. Hannes was not only an exceptional clinician scientist, but also…
A-TANGO related activities at EASL Congress 2026
Friday, 29 May 2026 A-TANGO Consensus Conference The A-TANGO Score: A Novel Tool for Risk Stratification and Clinical Endpoints in ACLF Rajiv Jalan (UCL) and Cornelius Engelmann (Charité) Track Hub 6 -…